Clicky

Veracyte, Inc.(VCYT)

Description: Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.


Keywords: Organ Systems Telemedicine Telehealth Lung Cancer Gene Expression Thyroid Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Surgeries Thyroid Cancer Human Anatomy Healthcare Costs Glands Metastases Thyroid Disease Thyroid Nodule Thyroid Nodules

Home Page: www.veracyte.com

VCYT Technical Analysis

6000 Shoreline Court
South San Francisco, CA 94080
United States
Phone: 650 243 6300


Officers

Name Title
Ms. Bonnie H. Anderson Co-Founder & Exec. Chairwoman
Mr. Marc A. Stapley CEO & Director
Ms. Rebecca Chambers Exec. VP & CFO
Dr. Giulia C. Kennedy Ph.D. Global Chief Scientific Officer & Chief Medical Officer
Dr. Tina S. Nova Ph.D. Pres of CLIA U.S. Bus.
Ms. Beverly Jane Alley CPA VP & Corp. Controller
Mr. Jonathan Wygant VP & Chief Accounting Officer
Mr. Steven French Sr. VP & Chief Information Officer
Ms. Annie McGuire Sr. VP & Gen. Counsel
Ms. Tracy Morris VP of Global Corp. Communications

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.9941
Price-to-Sales TTM: 7.1658
IPO Date: 2013-10-30
Fiscal Year End: December
Full Time Employees: 761
Back to stocks